Welcome to The Visible Embryo

Home- - -History-- -Bibliography- -Pregnancy Timeline- --Prescription Drugs in Pregnancy- -- Pregnancy Calculator- --Female Reproductive System- News Alerts -Contact

Welcome to The Visible Embryo, a comprehensive educational resource on human development from conception to birth.

The Visible Embryo provides visual references for changes in fetal development throughout pregnancy and can be navigated via fetal development or maternal changes.

The National Institutes of Child Health and Human Development awarded Phase I and Phase II Small Business Innovative Research Grants to develop The Visible Embryo. Initally designed to evaluate the internet as a teaching tool for first year medical students, The Visible Embryo is linked to over 600 educational institutions and is viewed by more than ' million visitors each month.

WHO International Clinical Trials Registry Platform
The World Health Organization (WHO) has created a new Web site to help researchers, doctors and patients obtain reliable information on high-quality clinical trials. Now you can go to one website and search all registers to identify clinical trial research underway around the world!




Pregnancy Timeline

Prescription Drug Effects on Pregnancy

Pregnancy Calculator

Female Reproductive System

Contact The Visible Embryo

News Alerts Archive

Disclaimer: The Visible Embryo web site is provided for your general information only. The information contained on this site should not be treated as a substitute for medical, legal or other professional advice. Neither is The Visible Embryo responsible or liable for the contents of any websites of third parties which are listed on this site.
Content protected under a Creative Commons License.

No dirivative works may be made or used for commercial purposes.

Return To Top Of Page
Pregnancy Timeline by SemestersFemale Reproductive SystemFertilizationThe Appearance of SomitesFirst TrimesterSecond TrimesterThird TrimesterFetal liver is producing blood cellsHead may position into pelvisBrain convolutions beginFull TermWhite fat begins to be madeWhite fat begins to be madeHead may position into pelvisImmune system beginningImmune system beginningPeriod of rapid brain growthBrain convolutions beginLungs begin to produce surfactantSensory brain waves begin to activateSensory brain waves begin to activateInner Ear Bones HardenBone marrow starts making blood cellsBone marrow starts making blood cellsBrown fat surrounds lymphatic systemFetal sexual organs visibleFinger and toe prints appearFinger and toe prints appearHeartbeat can be detectedHeartbeat can be detectedBasic Brain Structure in PlaceThe Appearance of SomitesFirst Detectable Brain WavesA Four Chambered HeartBeginning Cerebral HemispheresEnd of Embryonic PeriodEnd of Embryonic PeriodFirst Thin Layer of Skin AppearsThird TrimesterDevelopmental Timeline
Click weeks 0 - 40 and follow fetal growth
Google Search artcles published since 2007
Home--History--Bibliography- -Pregnancy Timeline- Prescription Drugs/Pregnancy- Pregnancy Calculator - Reproductive System- -News Alerts

January 17, 2012--------News Archive Return to: News Alerts

Retinoblastoma appears in newborn babies - it has even been
seen in infants born prematurely.

WHO Child Growth Charts

What Is Your BMI?


New Drug Target for Childhood Eye Cancer

Retinoblastoma is a rare childhood eye cancer caused by a single gene mutation. But that mutation changes the way cells turn on and off many other genes. This finding explains why retinoblastoma occurs at such a young age and suggests a new avenue for treatment.

Most cancers are caused by a process that spans decades. Cells gradually accumulate mistakes as they are copied again and again. When enough mistakes—in the form of genetic mutations—have built up, the cells don’t function normally anymore and start to resemble cancer, growing out of control. This is why the risk of most cancers increases with age. But retinoblastoma appears in newborn babies—it’s even been seen in infants born prematurely.

“It’s been considered a big paradox. How can retinoblastoma progress so quickly and acquire all the hallmarks of cancer? ” says Michael Dyer, an HHMI early career scientist at St. Jude Children’s Research Hospital. In a study published January 11, 2012 in the journal Nature, Dyer and colleagues provide an answer to that question.

Cancers are characterized by defects in multiple pathways. Cancer cells live longer than other cells, don’t die when exposed to factors that normally kill cells, divide and grow more quickly, and reorganize blood vessels and other tissues surrounding them. A single gene can’t make all these changes.

But scientists knew that a mutation in a single gene, RB1, was enough to cause retinoblastoma.

“Historically, the theory on retinoblastoma has been that this mutation in RB1 causes massive genome instability,” says Dyer. “Chromosomes start to acquire breaks and the genome gets all scrambled.” The scrambling of genes, researchers thought, explained how so many pathways stopped functioning correctly.

But when Dyer and his colleagues took tumors that had been surgically removed from childrens’ eyes and implanted them into the eyes of mice, they saw little evidence of genome instability.

“The tumors started growing and invading tissue almost immediately,” says Dyer, “behaving in the mice just as they had behaved in the human patients.” But when they tracked the genes in the tumors over time, nothing changed. All the genes remained the same for as long as nine months after the tumors were implanted in the mice.

“If RB1 mutations are causing genetic instability, then the more a tumor grows, the more scrambled the genes should become,” says Dyer. He saw no evidence of this. So he began to wonder how RB1 was causing so much cellular misregulation. He started to think that the answer might be explained by epigenetics, factors that influence the way genes are turned on and off, without altering DNA sequence.

Dyer’s team collected samples of retinoblastoma tumors and of normal eye tissue and compared them. They looked at chemical modifications that can turn genes on and off – known as epigenetic changes, as well as large structural changes that can determine which genes produce proteins. They also measured the amount of different genes that the cells were producing. In particular, they focused on genes known to have cancer-causing mutations.

“To our surprise and excitement, what we found was that instead of cancer genes having genetic mutations, they were being epigenetically regulated differently than normal cells,” says Dyer.

One gene jumped to the researchers’ attention. Called SYK, it’s known to cause leukemia when it’s mutated. It’s not turned on in normal eye tissue, but in the retinoblastoma samples, it was turned on to high levels.

There’s already a drug that blocks SYK being tested for both leukemia and rheumatoid arthritis, so Dyer had an easy way to turn the gene’s levels down. And when he blocked SYK with the drug, the tumor cells died—both in cancer cells grown in the lab as well as tumors in the eyes of mice.

Moreover, when Dyer looked at 82 retinoblastoma samples from humans, all 82 had high levels of the protein made by SYK. None of the normal eye samples did.

Even though there’s no mutation in SYK in retinoblastoma, Dyer says, RB1 influences the way cells turn genes on and off. Their experiments show that Rb turns on SYK, while it turns down the expression levels of other genes. The researchers have yet to work through the rest of the list of epigenetic differences they uncovered in retinoblastoma.

There’s likely many epigenetic changes influencing other cancer types, says Dyer, but it’s harder to sort out since there can also be thousands of gene mutations.

In the case of retinoblastoma, scientists now know that it’s one gene mutation causing a plethora of epigenetic changes. Whether they can block those changes, or target them with drugs one by one, it’s a leap in understanding a devastating cancer.

Original article: http://www.hhmi.org/news/dyer20120111.html